Endoscopic Ultrasound (EUS) Gastric Variceal Bleeding Database Repository
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Gastric Varices
- Sponsor
- Indiana University
- Enrollment
- 98
- Locations
- 1
- Primary Endpoint
- To determine the clinical impact of endoscopic ultrasound treatment of gastric variceal bleeding.
- Status
- Completed
- Last Updated
- 4 years ago
Overview
Brief Summary
The purpose of having a database is to collect data related to endoscopic ultrasound procedures performed by Indiana University EUS physicians; specifically, for the treatment of gastric variceal bleeding This data will be used for research purposes only to determine the clinical impact of endoscopic ultrasound treatment of gastric variceal bleeding. The physicians will also be able to better understand the patient's condition and disease process that may lead to improved standard of care and improved patient management.
Detailed Description
Clinical outcomes research is one of the strengths of the EUS group. As a group, the physicians need a tracking system for specific treatment modalities, and data to determine the impact of endoscopic ultrasound for patients with gastric variceal bleeding. Gastric variceal bleeding is a severe complication of portal hypertension with significant morbidity and mortality with limited therapeutic options. Currently, there is no database in existence for endoscopic ultrasound clinical research for specific procedures. Also, there is limited data regarding the outcome of endoscopic sclerotherapy with cyanoacrylate in the United States.
Investigators
John DeWitt
Director, Endoscopic Ulatrsound
Indiana University
Eligibility Criteria
Inclusion Criteria
- •Anyone receiving treatment with DermaBond for treatment gastric varices.
Exclusion Criteria
- •No evidence of gastric varices.
Outcomes
Primary Outcomes
To determine the clinical impact of endoscopic ultrasound treatment of gastric variceal bleeding.
Time Frame: 36 months
Patients with gastric variceal bleeding will be treated with DermaBond injection via EUS (endoscopic ultrasound). A follow-up EUS will observe the treated varices and determine if retreatment with DermaBond is necessary, or if observation alone is required.